Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B H Yagi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Anaerobe|August 5, 2006
In vitro activity of linezolid and eperezolid, two novel oxazolidinone antimicrobial agents, against anaerobic bacteriaB H Yagi, G E Zurenko
Diagnostic Microbiology and Infectious Disease|July 1, 1992
The bactericidal activity and postantibiotic effect of trospectomycinB H Yagi, R D Schaadt, G E Zurenko
Antimicrobial Agents and Chemotherapy|February 1, 1990
In vitro activity of cefpodoxime proxetil (U-76,252; CS-807) against Neisseria gonorrhoeaeR D Schaadt, B H Yagi, G E Zurenko
Antimicrobial Agents and Chemotherapy|February 1, 1988
In vitro antibacterial activity of trospectomycin (U-63366F), a novel spectinomycin analogG E Zurenko, B H Yagi, J J Vavra, et al.
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1991
Estimating the postantibiotic effect: a two-phase mathematical modelM N Brunden, B H Yagi, M S Lajiness, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1990
In vitro antibacterial activity and interactions with beta-lactamases and penicillin-binding proteins of the new monocarbam antibiotic U-78608G E Zurenko, S E Truesdell, B H Yagi, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1996
In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agentsG E Zurenko, B H Yagi, R D Schaadt, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
3-Arylpiperidines as potentiators of existing antibacterial agentsA Thorarensen, A L Presley-Bodnar, K R Marotti, et al.
Bioorganic & Medicinal Chemistry|November 17, 2001
Carbon-carbon-linked (pyrazolylphenyl)oxazolidinones with antibacterial activity against multiple drug resistant gram-positive and fastidious gram-negative bacteriaC S Lee, D A Allwine, M R Barbachyn, et al.
Journal of Medicinal Chemistry|December 19, 1998
Nitrogen-carbon-linked (azolylphenyl)oxazolidinones with potent antibacterial activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalisM J Genin, D K Hutchinson, D A Allwine, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Anaerobe|August 5, 2006
In vitro activity of linezolid and eperezolid, two novel oxazolidinone antimicrobial agents, against anaerobic bacteriaB H Yagi, G E Zurenko
Diagnostic Microbiology and Infectious Disease|July 1, 1992
The bactericidal activity and postantibiotic effect of trospectomycinB H Yagi, R D Schaadt, G E Zurenko
Antimicrobial Agents and Chemotherapy|February 1, 1990
In vitro activity of cefpodoxime proxetil (U-76,252; CS-807) against Neisseria gonorrhoeaeR D Schaadt, B H Yagi, G E Zurenko
Antimicrobial Agents and Chemotherapy|February 1, 1988
In vitro antibacterial activity of trospectomycin (U-63366F), a novel spectinomycin analogG E Zurenko, B H Yagi, J J Vavra, et al.
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1991
Estimating the postantibiotic effect: a two-phase mathematical modelM N Brunden, B H Yagi, M S Lajiness, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1990
In vitro antibacterial activity and interactions with beta-lactamases and penicillin-binding proteins of the new monocarbam antibiotic U-78608G E Zurenko, S E Truesdell, B H Yagi, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1996
In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agentsG E Zurenko, B H Yagi, R D Schaadt, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
3-Arylpiperidines as potentiators of existing antibacterial agentsA Thorarensen, A L Presley-Bodnar, K R Marotti, et al.
Bioorganic & Medicinal Chemistry|November 17, 2001
Carbon-carbon-linked (pyrazolylphenyl)oxazolidinones with antibacterial activity against multiple drug resistant gram-positive and fastidious gram-negative bacteriaC S Lee, D A Allwine, M R Barbachyn, et al.
Journal of Medicinal Chemistry|December 19, 1998
Nitrogen-carbon-linked (azolylphenyl)oxazolidinones with potent antibacterial activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalisM J Genin, D K Hutchinson, D A Allwine, et al.
Pageof 2